Home
Jubilant Pharmova Ltd EPS

Jubilant Pharmova Ltd
NSE: JUBLPHARMA
EPS
Key Highlights
- The Earning per Share of Jubilant Pharmova Ltd is ₹ 21.16 as of 04 Apr 25 .
- The earning per share of Jubilant Pharmova Ltd changed from ₹ 0.4 to ₹ 6.37 over 7 quarters. This represents a CAGR of 386.30% .
Historical Earning per Share of Jubilant Pharmova Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Jubilant Pharmova Ltd
Company Fundamentals for Jubilant Pharmova Ltd
Market Cap
14,794 Cr
EPS
21.2
P/E Ratio (TTM)
43.9
P/B Ratio (TTM)
2.5
Day’s High
973.7
Day’s Low
911.2
DTE
0.5
ROE
4.9
52 Week High
1309.0
52 Week Low
570.05
ROCE
7.5
Market Price of Jubilant Pharmova Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
04 Apr 2025 | 928.75 |
03 Apr 2025 | 971.65 |
02 Apr 2025 | 909.6 |
01 Apr 2025 | 914.4 |
28 Mar 2025 | 892.7 |
27 Mar 2025 | 891.75 |
26 Mar 2025 | 859.55 |
25 Mar 2025 | 870.55 |
24 Mar 2025 | 895.7 |
21 Mar 2025 | 902.55 |
SWOT Analysis Of Jubilant Pharmova Ltd
BlinkX Score for Jubilant Pharmova Ltd
Asset Value vs Market Value of Jubilant Pharmova Ltd
Market Value
₹ 14,795
Asset Value
Value addition
2.6 X
₹ 4,109
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Jubilant Pharmova Ltd | 14794 | 21.16 |
Sun Pharmaceutical Industries Ltd | 410142 | 49.16 |
Divis Laboratories Ltd | 145762 | 77.86 |
Cipla Ltd | 114322 | 61.78 |
Torrent Pharmaceuticals Ltd | 111166 | 55.02 |
Mankind Pharma Ltd | 101098 | 49.48 |
Company | |
---|---|
Jubilant Pharmova Ltd | 14794 |
Sun Pharmaceutical Industries Ltd | 410142 |
Divis Laboratories Ltd | 145762 |
Cipla Ltd | 114322 |
Torrent Pharmaceuticals Ltd | 111166 |
Mankind Pharma Ltd | 101098 |
Historical Market Cap of Jubilant Pharmova Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Jubilant Pharmova Ltd
Historical Revenue of Jubilant Pharmova Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Jubilant Pharmova Ltd
Historical EBITDA of Jubilant Pharmova Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Jubilant Pharmova Ltd
Historical Net Profit of Jubilant Pharmova Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Jubilant Pharmova Ltd
Dividend Payout Over Time
Jubilant Pharmova Ltd News Hub
Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories
Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant Biosys (J
Read more
16 Aug 24
Volumes soar at Jubilant Pharmova Ltd counter
Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Metals & Ene
Read more
01 Aug 24
Volumes soar at Jubilant Pharmova Ltd counter
Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are among the othe
Read more
09 Sept 24
Jubilant Pharmova Ltd leads gainers in 'A' group
Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are
Read more
09 Sept 24
Document
Concalls
Oct 2024
PPTJuly 2024
PPTMay 2024
PPTFeb 2024
PPTOct 2023
PPTJuly 2023
PPTMay 2023
PPTFeb 2023
TranscriptAug 2022
TranscriptJune 2022
TranscriptMar 2022
PPTJan 2022
TranscriptJuly 2021
TranscriptJan 2021
TranscriptOct 2024
PPTJuly 2024
PPTMay 2024
PPTFeb 2024
PPTOct 2023
PPTJuly 2023
PPTMay 2023
PPTFeb 2023
TranscriptAug 2022
TranscriptJune 2022
TranscriptMar 2022
PPTJan 2022
TranscriptJuly 2021
TranscriptJan 2021
Transcript